![Musk's Neuralink FDA review team hit by govt workforce reductions - Reuters](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEK4R0RM_L.jpg)
Please try another search
Date | Price | Open | High | Low | Change % |
---|---|---|---|---|---|
Feb 17, 2025 | 200.531 | 200.531 | 200.531 | 200.531 | 0.09% |
Feb 14, 2025 | 200.349 | 200.349 | 200.349 | 200.349 | -1.04% |
Feb 13, 2025 | 202.464 | 202.464 | 202.464 | 202.464 | -0.01% |
Feb 12, 2025 | 202.481 | 202.481 | 202.481 | 202.481 | 0.02% |
Feb 11, 2025 | 202.431 | 202.431 | 202.431 | 202.431 | -1.55% |
Feb 10, 2025 | 205.609 | 205.609 | 205.609 | 205.609 | -0.90% |
Feb 07, 2025 | 207.481 | 207.481 | 207.481 | 207.481 | -0.32% |
Feb 06, 2025 | 208.148 | 208.148 | 208.148 | 208.148 | -0.29% |
Feb 05, 2025 | 208.744 | 208.744 | 208.744 | 208.744 | 0.12% |
Feb 04, 2025 | 208.494 | 208.494 | 208.494 | 208.494 | 1.26% |
Feb 03, 2025 | 205.898 | 205.898 | 205.898 | 205.898 | -0.16% |
Jan 31, 2025 | 206.239 | 206.239 | 206.239 | 206.239 | 1.06% |
Jan 30, 2025 | 204.068 | 204.068 | 204.068 | 204.068 | 0.13% |
Jan 29, 2025 | 203.796 | 203.796 | 203.796 | 203.796 | 1.37% |
Jan 28, 2025 | 201.049 | 201.049 | 201.049 | 201.049 | 0.38% |
Jan 27, 2025 | 200.294 | 200.294 | 200.294 | 200.294 | -1.74% |
Jan 24, 2025 | 203.845 | 203.845 | 203.845 | 203.845 | -0.81% |
Jan 23, 2025 | 205.504 | 205.504 | 205.504 | 205.504 | 0.82% |
Jan 22, 2025 | 203.823 | 203.823 | 203.823 | 203.823 | 0.18% |
Jan 21, 2025 | 203.451 | 203.451 | 203.451 | 203.451 | -1.69% |
Jan 20, 2025 | 206.956 | 206.956 | 206.956 | 206.956 | 0.52% |
Highest: 208.744 | Lowest: 200.294 | Difference: 8.450 | Average: 204.364 | Change %: -2.603 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review